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Compared to in-centre, home hemodialysis is associated with superior outcomes. The
impact on patient experience and clinical outcomes of consistently providing the choice and
training to undertake hemodialysis-related treatment tasks in the in-centre setting is
unknown.
Methods
A stepped-wedge cluster randomised trial in 12 UK renal centres recruited prevalent in-cen-
tre hemodialysis patients with sites randomised into early and late participation in a 12-
month breakthrough series collaborative that included data collection, learning events,
Plan-Study-Do-Act cycles, and teleconferences repeated every 6 weeks, underpinned by a
faculty, co-production, materials and a nursing course. The primary outcome was the pro-
portion of patients undertaking five or more hemodialysis-related tasks or home hemodialy-
sis. Secondary outcomes included independent hemodialysis, quality of life, symptoms,
patient activation and hospitalisation. ISRCTN Registration Number 93999549.
Results
586 hemodialysis patients were recruited. The proportion performing 5 or more tasks or
home hemodialysis increased from 45.6% to 52.3% (205 to 244/449, difference 6.2%, 95%
CI 1.4 to 11%), however after analysis by step the adjusted odds ratio for the intervention
was 1.63 (95% CI 0.94 to 2.81, P = 0.08). 28.3% of patients doing less than 5 tasks at base-
line performed 5 or more at the end of the study (69/244, 95% CI 22.2–34.3%, adjusted
odds ratio 3.71, 95% CI 1.66–8.31). Independent or home hemodialysis increased from
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7.5% to 11.6% (32 to 49/423, difference 4.0%, 95% CI 1.0–7.0), but the remaining second-
ary endpoints were unaffected.
Conclusions
Our intervention did not increase dialysis related tasks being performed by a prevalent popu-
lation of centre based patients, but there was an increase in home hemodialysis as well as
an increase in tasks among patients who were doing fewer than 5 at baseline. Further stud-
ies are required that examine interventions to engage people who dialyse at centres in their
own care.
Introduction
When it was first developed, hemodialysis (HD) was predominantly undertaken at home,
however its widespread adoption as a treatment for end stage kidney disease (ESKD) in con-
junction with the increasing age and multi-morbidity of the patients receiving it, has led to in-
centre HD accounting for greater than 80% of dialysis in 79% of countries in the 2016 USRDS
annual report [1]. Home HD (HHD) is associated with better survival, quality of life and lower
costs compared with in-centre HD, and some of this advantage may relate to the enhanced
knowledge, skills and confidence that these individuals have to self-manage their condition
[2]. In recognition of the benefits of home dialysis The National Institute of Health and Care
Excellence recommended of a prevalence of 10–15% HHD in the UK, and a US presidential
executive order prioritised home dialysis therapies with financial incentives for providers to
meet targets [3].
Consistently offering in-centre HD patients the opportunity to learn about and participate
in their treatment potentially enables access to some of the health benefits that are associated
with HHD as well as impacting on patient activation and health literacy while aligning with
the goals of person-centred care [4,5]. Self-management programmes for in-centre hemodialy-
sis patients have been associated with improvements in empowerment, perceived self-efficacy,
medication adherence, phosphate control and interdialytic weight gain between dialysis ses-
sions which all correlate with mortality and symptom burden [6–10].
Shared Hemodialysis Care (SHC) is an educational quality improvement initiative consis-
tently provides the choice and opportunity for in-centre HD patients to learn about and
engage in their own treatment. The HD process is broken down into approximately 14 compo-
nent tasks, and patients are supported to participate at complexities and rates according to
individual preference (Table 1).
Table 1. Primary endpoint–five or more dialysis related tasks.











Needling fistula/graft or preparing tunnelled
line�
Connecting lines to fistula/graft/tunnelled
line and commencing dialysis�
Responding to machine alarms �
Disconnecting lines and completing
dialysis�
Applying pressure to needle sites or
locking tunnelled line
Giving your own anaemia injections
(such as epoetin)
� required tasks for independent haemodialysis endpoint.
https://doi.org/10.1371/journal.pone.0253966.t001
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In 2016 we initiated a program to scale up and spread SHC to 12 hospital sites in England.
To do this we developed a breakthrough series quality improvement collaborative (BTSC)
delivered through a series of learning events. These included a quality improvement curricu-
lum in which rapid tests of change were designed, performed and shared by contributing
teams, with the goal of altering dialysis unit organisation and culture to facilitate the imple-
mentation of SHC [11]. The objective of the study presented here was to test this complex,
multi-centre intervention. To do so we designed a stepped wedge cluster randomised trial
(SWCRT) of SHC delivered through a BTSC (SHAREHD) conducted across twelve renal cen-
tres with the primary endpoint being to increase the proportion of patients doing five or more
tasks or undertaking HD at home [12,13].
Materials andmethods
Study design
The trial design was an 18 month closed cohort stepped wedge cluster randomised trial
(SWCRT) conducted in 12 renal centres (units of cluster randomisation) in England, accord-
ing to a published protocol consistent with the extension to cluster randomized trials of the
Consolidated Standards Of Reporting [13]. It ran from October 2016 to March 2018: following
a control period of 6 months, the first group of 6 centres received the intervention and 6
months later the 6 remaining centres received it (Figs 1 and 2). The study adhered to the decla-
ration of Helsinki, ethical approval was obtained fromWest London & GTAC Research Ethics
Committee (IRAS project ID 212395). We focused on undertaking many of the other activities
involved in setting up the breakthrough series collaborative, engaging with the teams from the
centres and planning the various workstreams, and as a result the trial registration (ISRCTN
Number 93999549) was delayed until after the first patient had been consented. The authors
confirm that all ongoing and related trials for this intervention by this investigatory group are
registered. The protocol was published before the study was completed and before any results
were analysed [12].
Participants
The 12 renal centres had responsibility for the local organisation and delivery of HD treatment
and were invited to participate by the chief investigator (MEW) in October 2015. Between
October 2016 and February 2017 prevalent HD patients treated at these centres were
approached by research nurses, and written, informed consent was obtained to participate in a
questionnaire-based study. The specific details of the SWCRT and breakthrough series collab-
orative were not shared with the patients.
Inclusion criteria: Cluster level: English renal centres with a hospital or satellite-based
hemodialysis programme. Patient level: patients to be established on centre-based hemodialy-
sis and have capacity to give written informed consent. Exclusion criteria were those who are
too unwell to engage in the study, as judged by the clinical team, or unable to understand writ-
ten and verbal communication in English.
Centres participating in the trial were: Sheffield Teaching Hospital NHS Foundation Trust,
Central Manchester Healthcare Trust, City Hospitals Sunderland NHS Foundation Trust, East
& North Hertfordshire NHS Trust, Guy’s & St Thomas NHS Foundation Trust, Heart of
England Foundation Trust, Leeds teaching Hospitals NHS Trust, The Royal Wolverhampton
NHS Trust, North Bristol NHS Trust, University Hospital of North Midlands NHS Trust, Not-
tingham University Hospitals NHS Trust
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12
12
Clusters 6 Clusters 6
Baseline
Patients Screened 807 Patients Screened 744
Patients Consented 303 (37.5%) Patients Consented 283 (38.0%)
Clusters 6 Study Exits During Baseline Clusters 6
0 Discontinued Study (Clusters) 0
13 Discontinued Study (Patients) 12
5 Transplant 6
0 Peritoneal Dialysis 1
0 Discontinued HD 1
1 Transferred Centre 2
7 Died 2
Step 1
Participating Clusters 6 Participating Clusters 6
Intervention Clusters 6 Intervention Clusters 0
Participanting Patients 290 Study Exits During Step 1 Participanting Patients 271
0 Discontinued Study (Clusters) 0
29 Discontinued Study (Patients) 31
7 Transplant 6
4 Withdrew Consent 7
3 Discontinued HD 2
2 Transferred Centre 2
13 Died 14
Step 2
Participating Clusters 6 Participating Clusters 6
Intervention Clusters 6 Intervention Clusters 6
Participanting Patients 261 Participanting Patients 240
Study Exits During Step 2
0 Discontinued Study (Clusters) 0
55 Discontinued Study (Patients) 33
17 Transplant 9
0 Peritoneal Dialysis 1
5 Withdrew Consent 9
2 Discontinued HD 1
2 Transferred Centre 2
29 Died 11
Entering Sustain Overall Study Exits
Participating Clusters 6 0 Discontinued Study (Clusters) 0 Participating Clusters 6
Intervention Clusters 6 97 Discontinued Study (Patients) 76 Intervention Clusters 6
Participanting Patients 206 29 Transplant 21 Participanting Patients 207
0 Peritoneal Dialysis 2
9 Withdrew Consent 16
5 Discontinued HD 4
5 Transferred Centre 6
49 Died 27
Clusters Assessed for Eligibility
Randomised Clusters
Oct 2017 - 
March 2018
April 2018 - 
Sept 2018
Oct 2016 - 
March 2017










Fig 1. Study patient and cluster flow though the stepped wedge randomised controlled trial.
https://doi.org/10.1371/journal.pone.0253966.g001
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Randomisation and masking
In July 2016 the study statistician (SJW) used computer generated numbers to produce an allo-
cation sequence for the 12 dialysis centre clusters (6 early and 6 late). The study manager (SL)
then informed participating centres of their individual sequence after they had agreed to par-
ticipate in the trial. There was no patient-level stratification and neither clusters or patients
were blinded to the sequence allocation.
Procedures
The SHAREHD Intervention was delivered through a BTSC [14] involving implementation
teams from participating centres made up of approximately five individuals from each site
including nursing staff, clinicians, patient partners and additional personnel (e.g. psychologist,
service managers as determined by individual sites). Components of the collaborative are pre-
sented in Fig 3 with data in S1 Table. Teams met every six weeks at learning events designed to
enable adoption of SHC through sharing patient and clinician experiences, teaching and
reviewing improvement methodologies and designing PDSA cycles. Progress and outcome of













Oct 2016 - 
March 2017






April 2017 - 
Sept 2017
Fig 2. Diagram of stepped intervention across 12 clusters (renal centres).
https://doi.org/10.1371/journal.pone.0253966.g002
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these PDSA cycles was informed by real-time task data from participating patients and
reviewed at subsequent action period calls. The programme was led by a clinician (MEW),
programme manager (SL), patient representative (AH), rapid data analytics (JF) and
PROGRAMME INFRASTRUCTURE
Haemodialysis treatment task data from 50 paents
Provide common language & relevant paent data to 
inform shared care discussions and enable teams to 
target QI intervenons
Completed locally and reported back to 
the collaborave
To adapt the intervenon at sites using 
data to enable local adopon 




QI curriculum, co-design 
and feedback on progress, 
share learning including 






Share progress with 
PDSA cycles, enable 
















In order to co-produce 
the intervenon and 




informaon, share progress and 
message of #whyidosharedcare 
and effect culture change. 
Enabled health care 
staff to learn praccal 
aspects of Shared 
Haemodialysis Care
Site Iniaon Visit
Teams met in their own
environment to:
• Present objecves and 
expectaons of the program
• Understand local team 




Fig 3. Diagram of the SHAREHD intervention.
https://doi.org/10.1371/journal.pone.0253966.g003
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developmental evaluation of both the programme and the implementation at sites (SA). The
program was supported by bespoke materials (patient information leaflets, training manuals
and an adoption roadmap available via the SHC website) [15], social media (e.g. Facebook,
WhatsApp and @sharemydialysis on Twitter) and newsletters. An established SHC course for
health care staff was available and utilised by teams as required [16].
The BTSC was aligned with the SWCRT design. Two sequences of learning events each
containing teams from six participating sites were undertaken. The first sequence attended the
initial 4 events over six months. Sequence 2 then had a single event to learn key concepts fol-
lowed by 4 further events in combination with the sequence 1 sites (Figure in S1 Fig) over 6
months. Sites attended events and were instructed to apply their learning during transition or
intervention periods only.
Data from patients participating in the research study including endpoints were collected
using research nurse and self-completed paper instruments at three-monthly intervals for HD
tasks and six-monthly intervals for secondary endpoints with the exception of hospitalisation
which was obtained through data linkage to hospital episode statistics by the National Health
Service (NHS) Digital Data Access Request Service [17].
Outcomes
The primary binary outcome was a change in the proportion of participating hemodialysis
patients completing 5 or more out of 14 tasks (independently or supervised) or transferring to
HHD, sampled at three monthly intervals throughout the study. We selected 5 tasks as the pri-
mary outcome measure based on QI work conducted in Yorkshire and the Humber (UK) which
suggested that this number indicated patient engagement in the dialysis process through conduct-
ing tasks beyond handwashing and performing observations (Table 1) [18]. The secondary binary
outcome was an absolute increase in HHD and in-centre independent dialysis. These endpoints
were collected towards the end of each three-month period in order to allow patients time to have
been exposed to the intervention (Fig 2). Where observations were obtained during the transition
period between control and intervention these were assigned to the control.
The secondary endpoint of HHD or independent (completely self-caring) in-centre hemo-
dialysis was defined as the move to HHD or the tasks asterixed in Table 1. The secondary end-
points of change in patient activation; [4,19] quality of life (EQ-5D-5L) [20] and POS-S Renal
symptom score components (anxiety, depression and pain) [21] were measured six-monthly
at pre-defined timepoints. Hospitalisation was used to assess safety and adverse events, and
was assessed as change in all-cause and cause specific–dialysis access, fluid overload and car-
diovascular events based on ICD10 codes (data in S2 Table).
Statistical analysis
Using a recommended ICC value of 0.05 [22], A SWCRT design of 3 steps (including baseline)
and 12 clusters of 25 patients, with 6 clusters randomised at each step, would have a 90%
power to detect an increase in event rate from 15% to 30% [23] as statistically significant at the
5% two-sided level. Assuming the baseline independent in-centre HD rate was around 2% in
participating clusters with the same assumptions as the primary endpoint the SWCRT design
has 80% power to detect an increase in the event rate from 2% to 7.2% as statistically significant
at the 5% two-sided level. In recognition of the background mortality and renal transplanta-
tion rate and to mitigate the risk of incomplete data collection, the target recruitment per par-
ticipating site was doubled to 50.
Absolute changes in primary and secondary endpoints were assessed comparing the first
available observation for all patients during the baseline period with the last available
PLOS ONE RCT of increasing patient HD tasks
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observation for all patients during the second step. The categorical primary endpoints of five
tasks or home HD and secondary endpoints of anxiety, depression and pain (absent or mild
compared to moderate, severe or overwhelming due to their distribution) and hospitalisation
per three-month period were analysed using mixed effects logistic regression performed on all
observations and including the stepped wedge randomly assigned exposure to the control or
intervention at the time of data collection (intention to treat). Continuous endpoints including
numbers of tasks, patient activation measure score and EQ5D utility were analysed using
mixed effects linear regression adopting the same approach as above. Primary and secondary
outcomes were evaluated accounting for clustering within participating renal centres using a
random intercept (a centre-specific baseline proportion or an endpoint), and within patient
using a random intercept (a patient-specific baseline proportion of an endpoint). All multivar-
iable models were adjusted for the baseline variables of age (<35, 35–49, 50–64, 65–79, 80+),
gender, time on dialysis (years), marital status, health literacy (adequate defined as “somewhat”
or better to the question “How confident are you filling out medical forms by yourself?” [24]),
EQ5D utility value and comorbid score derived from linked administrative data [25]. Baseline
EQ5D utility score was included in all models except when it was analysed as secondary out-
come measure. Endpoints are reported with and without adjustment for time (measured in
months from beginning of baseline period) to account for any underlying secular trends in
endpoints [13]. A patient was censored from primary and secondary endpoint analyses if they
were transplanted, switched to peritoneal dialysis, withdrew consent, moved centre, discontin-
ued dialysis or died. Incident dialysis patients were defined as receiving dialysis for less than
six months and prevalent longer than six months at study inception.
Prespecified sensitivity analyses exploring the effect of the intervention on subgroups of
individuals were defined in our analysis plan and reviewed by our evaluation advisory board.
All analyses were performed on STATA version 14.2 (StataCorp. 2015. College Station, TX).
Results
The 12 participating renal centres were identified and agreed to participate between June and Sep-
tember 2015. Between October 2016 and January 2017 1551 patients were screened across the 12
centres and 586 patients consented to participate (303 in the 6 centres that began the intervention
January 2017 and 283 patients in the 6 centres that began the intervention in July 2017, Figs 1 and
2). There were no deviations from the scheduled steps and no clusters were lost during the trial.
The fidelity of the intervention was evaluated based on the conduct and participation in learning
events and action period calls, PDSA cycles and task data collection (data in S1 Text).
Patient characteristics and numbers analysed
The baseline characteristics of the patients recruited into the trial are detailed in Table 2, strati-
fied by the randomisation and their baseline primary endpoint status. Patient characteristics
by cluster are available in data in S4 Table. The flow of patients and renal centres through the
two stepped sequences is illustrated in Fig 1, showing that by the end of the 18 month study
173 patients (29.5%) of patients had discontinued the study, however missing data for HD
tasks (n = 8) and adjustment variables (n = 179) resulted in the exclusion of 187 patients from
the multi-variable logistic regression model assessing the primary endpoint of proportion
undertaking 5 or more HD tasks or home hemodialysis.
Outcomes and estimation
Of the 449 patients who had their tasks measured during both baseline and intervention peri-
ods, the number undertaking five or more tasks independently or supervised increased from
PLOS ONE RCT of increasing patient HD tasks
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205 to 244 following the intervention (45.6% vs 52.3%, absolute change 6.2%, P = 0.010, 95%
CI: 1.4 to 11.0%).
The trend in patients performing five or more tasks or undertaking home hemodialysis is
shown in Fig 4A, stratified by randomised sequence. The time adjusted odds ratio for the
Table 2. Baseline patient characteristics.
Randomisation Baseline Ind/Sup Tasks Observed values
Sequence 1 Sequence 2 <5 > = 5
n 303 283 321 253
Age (years) 62.8 (15.6) 62.9 (15.6) 65.8 (15.6) 59.2 (14.8) 547
Time since first dialysis (years) 5.1 (5.4) 5.8 (8) 4.3 (4.9) 6.7 (8.1) 498
Gender (Male) 179 (60.9%) 148 (62.2%) 174 (60.2%) 152 (62.8%) 532
Ethnicity (Caucasian) 250 (85.6%) 180 (76.9%) 242 (84.6%) 187 (78.2%) 526
Comorbidities 520
Chronic Obstructive Pulmonary Dis. 25 (8.9%) 27 (10.8%) 32 (10.9%) 19 (8.4%)
Heart Failure 51 (18.2%) 51 (20.3%) 65 (22.1%) 36 (15.9%)
Cerebrovascular Disease 20 (7.1%) 25 (10.0%) 33 (11.2%) 12 (5.3%)
Previous Myocardial Infarction 59 (21%) 43 (17.1%) 65 (22.1%) 36 (15.9%)
Lymphoma 3 (1%) 5 (2.0%) 4 (1.4%) 3 (1.3%)
Neurological Disease 16 (5.7%) 9 (3.6%) 17 (5.8%) 8 (3.5%)
Vascular Procedure 8 (2.9%) 9 (3.6%) 13 (4.4%) 4 (1.8%)
Valvular Heart Disease 44 (15.7%) 38 (15.1%) 51 (17.4%) 29 (12.8%)
Cancer 24 (8.5%) 20 (8.0%) 21 (7.1%) 21 (9.3%)
Connective Tissue Disease 12 (4.3%) 15 (6.0%) 15 (5.1%) 12 (5.3%)
Diabetes 112 (39.9%) 104 (41.4%) 129 (43.9%) 84 (37.2%)
Comorbid Score 1.51 (1.38) 1.55 (1.42) 1.71 (1.45) 1.33 (1.31) 520
EQ5D Utility 0.68 (0.27) 0.71 (0.26) 0.67 (0.28) 0.74 (0.23) 485
PAM score 56.2 (18.6) 58.3 (19) 50.8 (15.6) 64.3 (19.6) 456
PAM level 456
1—Passive & Overwhelmed 80 (31.5%) 50 (24.8%) 93 (38.3%) 37 (17.4%)
2—Lack Knowledge & Confidence 57 (22.4%) 38 (18.8%) 66 (27.2%) 29 (13.6%)
3—Taking Action 75 (29.5%) 70 (34.7%) 66 (27.2%) 79 (37.1%)
4—Adopted behaviours 42 (16.5%) 44 (21.8%) 18 (7.4%) 64 (31.9%)
Anxiety (moderate or worse) 74 (28.1%) 55 (24.4%) 64 (24.8%) 65 (28.3%) 488
Depression (moderate or worse) 73 (27.9%) 41 (18.2%) 61 (23.7%) 53 (23.0%) 488
Pain (moderate or worse) 104 (39.5%) 84 (37.8%) 105 (40.9%) 83 (36.4%) 487
Poor Mobility (moderately impaired or worse) 152 (57.4%) 99 (44.0%) 149 (57.1%) 102 (44.5%) 490
Limited Health Literacy 73 (28.0%) 54 (24.4%) 85 (31.0%) 42 (17.7%) 482
Education (no formal qualification) 108 (37.8%) 71 (30.0%) 107 (38.1%) 71 (29.6%) 522
Number of tasks (mean)
Independent or Supervised 5 (4.1) 5.1 (3.9) 2.3 (1.3) 8.6 (3.4) 574
Independent 4.3 (3.8) 3.9 (3.3) 2 (1.2) 6.9 (3.6) 574
Interest in Home HD 546
Yes 40 (13.9%) 41 (15.9%) 33 (10.7%) 48 (20.3%)
No 202 (70.1%) 179 (69.4%) 234 (75.7%) 147 (62.0%)
Maybe 46 (16.0%) 38 (14.7%) 42 (13.6%) 42 (17.7%)
Self-needling interest (probably do it or better) 84 (35.9%) 61 (32.6%) 50 (23.0%) 95 (46.6%) 421
Full list of POS-S symptoms available in data in S3 Table.
https://doi.org/10.1371/journal.pone.0253966.t002
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intervention for undertaking five or more tasks independently or supervised or home hemodi-
alysis was 1.62 (95% CI 1.02–2.60, P = 0.043) in analyses not including baseline variables and
1.63 (95% CI 0.94–2.81, P = 0.080) in the analysis adjusted for baseline covariates (Table 3).
Changes in individual tasks are shown in Fig 5, showing improvements in the proportion
doing both supervised and unsupervised tasks, and are reported stratified by number of base-
line tasks in supplementary figures (figure in S2 Fig, figure in S3 Fig).
The proportion of patients performing their dialysis independently in centre was 5.2% (21/
402) at the end of the baseline period and 6.9% (28/402) at the end of the study (absolute differ-
ence 1.7%, 95%CI -1.0 to 4.5%) and 21 patients (5.0% of 402 completing the study) moved
from in-centre to home HD. The overall improvement of this combined endpoint was from
7.6% to 11.6% (difference 4.0%, 95% CI 1.0% to 7.0%), however the relatively small number of
events precluded the use of a multi-level multivariable model on this endpoint.
Fig 4. Secular trend of primary endpoint (5 or more tasks or home hemodialysis). (A) Overall, according to
sequence of randomisation (B) Secular trend of the primary endpoint stratified by number of tasks at baseline. (C)
Secular trend of the primary endpoint stratified by incident (within 6 months of starting hemodialysis) or prevalent (6
months or longer on hemodialysis).
https://doi.org/10.1371/journal.pone.0253966.g004
Table 3. Primary endpoint of five or more tasks or home hemodialysis, and secondary endpoints: Effect sizes.
Endpoint Analysis Time (per
month)
Effect Size of Intervention (95% CI) P N ICC centre ICC patient
PRIMARY ENDPOINT
Primary—5+ Tasks or HHD
Absolute Proportion doing tasks 45.6% (205/449) vs 52.3% (244/449) Difference 6.2% (1.4–
11.0)
0.01
Crude OR 1.00 (0.96–1.05) 1.62 (1.02–2.60) 0.043 578 0.237 0.818
Multivarable adjusted OR 1.01 (0.95–1.05) 1.63 (0.94–2.81) 0.08 399 0.220 0.762
Crude OR without time - 1.68 (1.28–2.21) <0.001 578 0.237 0.818
Multivarable adjusted OR without time - 1.59 (1.16–2.19) 0.004 399 0.220 0.762
SECONDARY ENDPOINTS
Independent ICHD or HHD 7.5% (32/423) vs 11.6% (49/423) Difference 4.0 (1.0–7.0) 0.008
Number of tasks (Independent or
Supervised)
0.01 (-0.05–0.08) 0.31 (-0.26–0.89) 0.283 399 0.179
Number of tasks (Independent) 0.05 (-0.01–0.10) 0.21 (-0.31–0.72) 0.43 399 0.170
Patient Activation Score (0–100) -0.12 (-0.53–0.28) 1.26 (-2.88–5.41) 0.551 393 0.063
EQ5D Utility Value (0: Dead, 1: Perfect
Health)
0.0 (-0.01–0.00) 0.01 (-0.06–0.07) 0.806 409 0.049
Depression (Moderate or worse, OR) 1.01 (0.93–1.10) 1.05 (0.46–2.40) 0.916 390 0.006 0.513
Anxiety (Moderate or worse, OR) 1.00 (0.91–1.08) 0.90 (0.43–1.90) 0.787 390 0.006 0.464
Pain (Moderate or worse, OR) 0.96 (0.90–1.03) 1.89 (0.99–3.61) 0.054 390 0.000 0.359
All Cause Hospitalisation OR 1.00 (0.97–1.04) 1.00 (0.68–1.47) 1.000 399 0.007 0.170
Infection Hospitalisation OR 1.01 (0.95–1.08) 1.15 (0.62–2.11) 0.662 399 0.000 0.063
Fluid Overload Hospitalisation OR 1.10 (0.98–1.23) 0.24 (0.07–0.80) 0.019 399 0.065 0.065
Vascular Access Hospitalisation OR 1.08 (1.00–1.17) 0.78 (0.35–1.75) 0.551 399 0.000 0.032
Emergency Room Attendance OR 1.02 (0.98–1.05) 1.00 (0.70–1.42) 0.985 399 0.000 0.176
OR: Odds Ratio. Mixed effects logistic or linear regression model with a random effects (random intercept for cluster and participant where ICC patient quoted) and
fixed effects for intervention and time and baseline covariates. Adjusted for the baseline variables of age (categories), gender, time on dialysis (years), marital status,
health literacy (adequate or inadequate), EQ5D utility value and comorbid score (derived from chronic obstructive pulmonary disease, congestive cardiac failure,
cerebrovascular accident, acute myocardial infarction, neurological disease, vascular intervention, valvular heart disease, cancer, connective tissue disease and diabetes).
https://doi.org/10.1371/journal.pone.0253966.t003
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There was no statistically significant impact of the stepped intervention on the patient acti-
vation measure1 (adjusted mean difference 1.26, 95% CI -2.88 to 5.41, P = 0.551), EQ5D
quality of life (adjusted mean difference 0.01, 95% CI -0.06 to 0.07, P = 0.806), number of HD
tasks, or symptoms of depression, anxiety or pain (Table 3, figure in S4 Fig). There was no sig-
nificant difference in hospitalisation according to exposure to the intervention (Table 3, data
in S6 Table, figure in S5 Fig).
Subgroup and sensitivity analyses
Stratifying by the primary endpoint of five or more tasks at baseline showed differing effects of
the intervention. 80.0% (123/205, 95% CI 74.7–85.7%, P<0.001) of patients who began the
study doing five or more tasks were still doing five or more at the end of the study, whereas
28.3% (69/244, 95% CI 22.2–34.3, P<0.001) who began the study doing less than five tasks
were doing more than five tasks at the end of the study (Fig 4B). The time and multi-variable
adjusted odds ratio effect of the intervention in patients doing less than 5 tasks at baseline was
3.71 (95% CI 1.66–8.31, P = 0.024, data in S5 Table). Having removed time from the endpoint
models the odds ratio for patients completing five or more tasks or performing home hemodi-
alysis was 1.59 (95% CI 1.16–2.19, P = 0.004, Table 3).
Discussion
This 12-site stepped wedge cluster randomised trial (SWCRT) evaluating a breakthrough series
collaborative (BTSC) supporting patients to learn treatment related tasks significantly
improved the absolute proportion of patients undertaking the combined end-point of 5 of
more HD tasks or home HD, however the adjusted odds ratio for the intervention was not sig-
nificant. Significant increases in the combined end-point of dialyzing independent in-centre
and home HD were observed, as was the increase in participation in HD tasks in patients who
were performing fewer than 5 dialysis tasks at baseline. However, the secondary endpoints of
patient activation, EQ5D quality of life and hospitalisation were unaltered.
Demonstrating the impact of quality interventions in kidney disease is challenging, how-
ever there is evidence for the use of quality improvement collaboratives in renal replacement
therapy [26], particularly around the reduction of central venous catheter infection rates and
peritoneal infection rates but this approach has not been used to deliver self-management sup-
port in dialysis [27], Despite associations between improved health-related quality of life and
HHD and the SHC intervention being effective in promoting independent and home HD,
gains in health-related quality of life not observed. Our study did not identify increased infec-
tion- and dialysis-access-related hospitalisations associated with performing more tasks, unlike
observational data from the US showing increases in these events in home- compared to in-
centre patients [28]. The observed reduction in fluid overload admissions may be a conse-
quence of patients performing their own weight and programming their HDmachines leading
to improved knowledge around fluid management [29].
The strengths of this study include that it was multi-centre and of relatively large size and
that groups were well randomised at baseline. In order to maintain external generalizability
inclusion criteria were broad and consented patients were representative of the prevalent HD
population including the multi-morbidity associated with this group. The BTSC and associ-
ated co-production with service users resulted in adaption of the intervention at participating
Fig 5. Patient participation in individual dialysis tasks at baseline and end of the stepped wedge randomised
controlled trial in individuals with data at both timepoints (n = 427). Categories: Independent (blue), Supervised
(green), and Not Doing (red). Figure stratified by baseline participation: Figure in S2 Fig and figure in S3 Fig.
https://doi.org/10.1371/journal.pone.0253966.g005
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sites to take account of contextual issues which can impact on intervention efficacy [30]. The
SWCRT design enabled cost-effective evaluation of the impact of this complex intervention on
the longitudinal changes in endpoints using a closed design [26]. However, a weakness of the
that design was that all patients received the intervention during the final phase when they
were potentially at their frailest due to the progressive impact of their medical condition. This
increasing frailty may have contributed to a reduced dialysis task participation during the
course of the study among those who were undertaking more than 5 tasks at the outset, and
baseline frailty could have prevent a subgroup of individuals with low task participation at
baseline from increasing their task participation. The combination of these factors and the
inclusion of time in the outcome models may have resulted in an under estimation of the effect
of the intervention, and for this reason and in line with guidance we report our models both
with and without time included [13,31]. Other weaknesses included missing data reducing the
sample size for multivariable models, a higher than expect baseline rate of dialysis-related tasks
(45.6 observed vs 15% assumed) and centre interclass correlation (observed 0.179 vs 0.05
assumed), the unblinded assessment of patient tasks and that the act of collecting task data led
to greater engagement during control periods.
Healthcare providers intending to increase home dialysis use may consider the SHC inter-
vention since this study demonstrated impact on independent and home HD use. The inter-
vention had the greatest impact on individuals who were undertaking fewer tasks at baseline
and possibly those with the lowest levels of patient activation. However, as individuals per-
forming fewer tasks at baseline appear to be more comorbid if they increased their number of
tasks are a result of the intervention, they could subsequently reduce their number of tasks due
to this frailty. Future interventions in this area should explore approaches to rehabilitate indi-
viduals whose self-efficacy has acutely or chronically declined, and intervention/trial designs
that focus on incident patients and utilise Transitional Care Units to support individuals who
are starting dialysis to learn tasks [32].
In conclusion, despite the difficulties of studying a prevalent, highly co-morbid dialysis
population, the delivery of a break-through series collaborative designed to support greater
patient participation in centre-based HD was safe and effective at improving the number of
individuals performing dialysis independently or at home, and increased HD tasks in-centre
among patients who were performing less than five. Recognition of the impact of this interven-
tion while acknowledging the tendency for patients to become frailer over time are important
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